Biocytogen

Biocytogen

Advanced biotechnology company.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD552m (Public information from Sep 2022)
Wakefield Massachusetts (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-
*
N/A

N/A

Series A

N/A

Series B

JPY410m

Series C

$77.1m

Series D

$142m

Series D

$10.0m

Valuation: $710m

Late VC
*
N/A

$60.0m

Valuation: $357m

IPO
Total FundingAUD359m

Recent News about Biocytogen

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.